SK20242000A3 - Paroxetínová soľ, spôsob jej prípravy a jej použitie - Google Patents

Paroxetínová soľ, spôsob jej prípravy a jej použitie Download PDF

Info

Publication number
SK20242000A3
SK20242000A3 SK2024-2000A SK20242000A SK20242000A3 SK 20242000 A3 SK20242000 A3 SK 20242000A3 SK 20242000 A SK20242000 A SK 20242000A SK 20242000 A3 SK20242000 A3 SK 20242000A3
Authority
SK
Slovakia
Prior art keywords
acid
benzoic
carboxylic
methyl
chloro
Prior art date
Application number
SK2024-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Victor Witold Jacewicz
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK20242000A3 publication Critical patent/SK20242000A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK2024-2000A 1998-07-02 1999-06-30 Paroxetínová soľ, spôsob jej prípravy a jej použitie SK20242000A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds
PCT/EP1999/004543 WO2000001692A1 (en) 1998-07-02 1999-06-30 Salts of paroxetine

Publications (1)

Publication Number Publication Date
SK20242000A3 true SK20242000A3 (sk) 2001-07-10

Family

ID=10834803

Family Applications (1)

Application Number Title Priority Date Filing Date
SK2024-2000A SK20242000A3 (sk) 1998-07-02 1999-06-30 Paroxetínová soľ, spôsob jej prípravy a jej použitie

Country Status (21)

Country Link
EP (1) EP1091958A1 (cs)
JP (1) JP2002519421A (cs)
KR (1) KR20010053337A (cs)
CN (1) CN1314906A (cs)
AP (1) AP2000002017A0 (cs)
AU (2) AU4903999A (cs)
BG (1) BG105204A (cs)
BR (1) BR9911679A (cs)
CA (1) CA2336470A1 (cs)
CZ (1) CZ20004923A3 (cs)
EA (1) EA200100098A1 (cs)
GB (1) GB9814316D0 (cs)
HU (1) HUP0103712A3 (cs)
ID (1) ID27766A (cs)
IL (1) IL140385A0 (cs)
NO (1) NO20006547L (cs)
PL (1) PL345365A1 (cs)
SK (1) SK20242000A3 (cs)
TR (1) TR200100055T2 (cs)
WO (1) WO2000001692A1 (cs)
ZA (2) ZA992899B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1534305E (pt) 2003-05-07 2007-02-28 Osteologix As Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis
PT1622630E (pt) 2003-05-07 2012-10-11 Osteologix As Combinações de estrôncio para a profilaxia/tratamento de patologias da cartilagem e/ou do osso
US20080167513A1 (en) 2004-02-26 2008-07-10 Osteologlx A/S Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions
JP4954867B2 (ja) 2004-05-06 2012-06-20 オステオロジックス エイ/エス 有機金属塩類を製造するための高収率で迅速な合成法
KR100672184B1 (ko) * 2004-09-21 2007-01-19 주식회사종근당 파록세틴의 콜린산 또는 콜린산 유도체 염
ES2745411T3 (es) * 2006-07-27 2020-03-02 Wang Nai Fang Compuestos y composiciones de arilsulfanilo para administración de agentes activos
CN109212055B (zh) * 2018-08-19 2021-05-07 丁立平 一种测定饮用水中四种痕量单卤代苯乙酸的气相色谱-质谱联用法
CN109342633B (zh) * 2018-11-27 2020-10-02 北京市化工职业病防治院 尿液中苯、甲苯和二甲苯代谢物的检测方法
CN111337460B (zh) * 2018-12-18 2021-09-17 中国科学院大连化学物理研究所 一种高稳定性Halo-tag探针及其合成和生物应用
CN116283778B (zh) * 2023-02-23 2025-08-29 江苏理工学院 一种吡唑羧酸类化合物及其制备方法和应用
US20250091996A1 (en) 2023-09-15 2025-03-20 King Faisal University 2-(1h-imidazole-1-carbonyl)benzoic acid as an anticancer compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
JP2002503248A (ja) * 1997-06-10 2002-01-29 シントン・ベスローテン・フェンノートシャップ 4−フェニルピペリジン化合物
EP1053234A1 (en) * 1998-02-06 2000-11-22 Smithkline Beecham Plc Salts of paroxetine

Also Published As

Publication number Publication date
AU2002100370A4 (en) 2002-06-06
CA2336470A1 (en) 2000-01-13
ZA200100020B (en) 2002-03-25
AU4903999A (en) 2000-01-24
ID27766A (id) 2001-04-26
KR20010053337A (ko) 2001-06-25
NO20006547D0 (no) 2000-12-21
EP1091958A1 (en) 2001-04-18
PL345365A1 (en) 2001-12-17
BR9911679A (pt) 2002-01-29
CN1314906A (zh) 2001-09-26
AP2000002017A0 (en) 2000-12-31
CZ20004923A3 (cs) 2001-08-15
JP2002519421A (ja) 2002-07-02
HUP0103712A3 (en) 2002-09-30
HUP0103712A2 (hu) 2002-05-29
WO2000001692A1 (en) 2000-01-13
ZA992899B (en) 2000-03-29
IL140385A0 (en) 2002-02-10
EA200100098A1 (ru) 2001-08-27
GB9814316D0 (en) 1998-09-02
BG105204A (en) 2001-11-30
NO20006547L (no) 2001-02-12
TR200100055T2 (tr) 2001-07-23

Similar Documents

Publication Publication Date Title
SU1097194A3 (ru) Способ получени производных феноксиалкилкарбоновой кислоты, а также их натриевых солей, сложных эфиров и амидов
AU4903999A (en) Salts of paroxetine
DE69527798T2 (de) Substituierte 4-biarylbutyr-oder 5-biarylpentasäuren und derivate als matrix metalloprotease inhibitoren
RU2529484C2 (ru) Ациламино-замещенные производные конденсированных циклопентанкарбоновых кислот и их применение в качестве фармацевтических средств
DE69514813T2 (de) Bicyclische diarylheterocyclen als cyclooxygenase-2-inhibitoren
CA2401778A1 (en) Benzamides and related inhibitors of factor xa
KR100938950B1 (ko) 치환 페닐 알칸산 유도체 및 그 용도
IE43142B1 (en) Phenylacetic acid derivatives
JP2010143937A (ja) 抗凝血薬として用いるクマリン誘導体
DE69023960T2 (de) Phenylalkan(en)säuren.
GB1476214A (en) Dibenzoxepin derivatives process for the preparation thereof and pharmaceutical compositions containing them
MXPA01000133A (en) Salts of paroxetine
SE9300013L (sv) Nytt förfarande och mellanprodukter för framställning av pro- läkemedel
KR100338999B1 (ko) 고지혈증치료제
JPH0278675A (ja) ベンゾフラニル酢酸誘導体、その製法、粘液調節剤および抗ヒスタミン剤
ES446691A1 (es) Procedimiento para la preparacion de nuevos acidos 3-(4-bi- fenilil)-butiricos, sus esteres y amidas.
KR20080015788A (ko) GlyR의 조정제 또는 아고니스트인 벤조산 유도체
PT83667B (pt) Processo para a preparacao de acidos e esteres {{{(3-piridinil)metileno}amino}oxi}-alcanoicos e de composicoes farmaceuticas que os contenham
WO2002004439A3 (en) Thiophene retinoids
JPH02124869A (ja) ロイコトリエン拮抗剤のエステルプロドラッグ
RU96119966A (ru) Производное хинола для лечения недержания мочи
DE68913159T2 (de) Thiophencarboxamid-Derivate und ihre Verwendung als Heilmittel.
WO2012174926A1 (zh) N-取代异丙二甲薁磺酰胺类衍生物及其制备方法和用途
EP0710665A1 (en) Phosphonosulfonate squalene synthetase inhibitor salts and method
JPS58201762A (ja) 3−カルボキシ−1,4−ジメチルピロ−ル−2−酢酸の製造方法